185 related articles for article (PubMed ID: 22848758)
1. XMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22Rv1 cells a suitable prostate cancer model?
Stieler K; Schumacher U; Horst AK; Fischer N
PLoS One; 2012; 7(7):e42321. PubMed ID: 22848758
[TBL] [Abstract][Full Text] [Related]
2. Xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer cells likely represents a laboratory artifact.
Yang J; Battacharya P; Singhal R; Kandel ES
Oncotarget; 2011 May; 2(5):358-62. PubMed ID: 21642749
[TBL] [Abstract][Full Text] [Related]
3. Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1.
Das Gupta J; Luk KC; Tang N; Gaughan C; Klein EA; Kandel ES; Hackett J; Silverman RH
PLoS One; 2012; 7(5):e36072. PubMed ID: 22615748
[TBL] [Abstract][Full Text] [Related]
4. XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27(Kip1).
Pandhare-Dash J; Mantri CK; Gong Y; Chen Z; Dash C
Prostate; 2012 Jun; 72(8):886-97. PubMed ID: 21932423
[TBL] [Abstract][Full Text] [Related]
5. Disease-associated XMRV sequences are consistent with laboratory contamination.
Hué S; Gray ER; Gall A; Katzourakis A; Tan CP; Houldcroft CJ; McLaren S; Pillay D; Futreal A; Garson JA; Pybus OG; Kellam P; Towers GJ
Retrovirology; 2010 Dec; 7(1):111. PubMed ID: 21171979
[TBL] [Abstract][Full Text] [Related]
6. Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels.
Murgai M; Thomas J; Cherepanova O; Delviks-Frankenberry K; Deeble P; Pathak VK; Rekosh D; Owens G
Retrovirology; 2013 Mar; 10():34. PubMed ID: 23537062
[TBL] [Abstract][Full Text] [Related]
7. Recombinant origin of the retrovirus XMRV.
Paprotka T; Delviks-Frankenberry KA; Cingöz O; Martinez A; Kung HJ; Tepper CG; Hu WS; Fivash MJ; Coffin JM; Pathak VK
Science; 2011 Jul; 333(6038):97-101. PubMed ID: 21628392
[TBL] [Abstract][Full Text] [Related]
8. In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer.
Lee D; Das Gupta J; Gaughan C; Steffen I; Tang N; Luk KC; Qiu X; Urisman A; Fischer N; Molinaro R; Broz M; Schochetman G; Klein EA; Ganem D; Derisi JL; Simmons G; Hackett J; Silverman RH; Chiu CY
PLoS One; 2012; 7(9):e44954. PubMed ID: 23028701
[TBL] [Abstract][Full Text] [Related]
9. Recombinant origin, contamination, and de-discovery of XMRV.
Delviks-Frankenberry K; Cingöz O; Coffin JM; Pathak VK
Curr Opin Virol; 2012 Aug; 2(4):499-507. PubMed ID: 22818188
[TBL] [Abstract][Full Text] [Related]
10. Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells.
Knouf EC; Metzger MJ; Mitchell PS; Arroyo JD; Chevillet JR; Tewari M; Miller AD
J Virol; 2009 Jul; 83(14):7353-6. PubMed ID: 19403664
[TBL] [Abstract][Full Text] [Related]
11. NF-kappaB activation stimulates transcription and replication of retrovirus XMRV in human B-lineage and prostate carcinoma cells.
Sakakibara S; Sakakibara K; Tosato G
J Virol; 2011 Apr; 85(7):3179-86. PubMed ID: 21270144
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of APOBEC3G by xenotropic murine leukemia-virus related virus (XMRV) in prostate cancer cells.
Dey A; Mantri CK; Pandhare-Dash J; Liu B; Pratap S; Dash C
Virol J; 2011 Dec; 8():531. PubMed ID: 22152111
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of human lymphoid tissue cultured ex vivo to xenotropic murine leukemia virus-related virus (XMRV) infection.
Curriu M; Carrillo J; Massanella M; Garcia E; Cunyat F; Peña R; Wienberg P; Carrato C; Areal J; Bofill M; Clotet B; Blanco J; Cabrera C
PLoS One; 2012; 7(5):e37415. PubMed ID: 22616002
[TBL] [Abstract][Full Text] [Related]
14. Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus.
Kakoki K; Kamiyama H; Izumida M; Yashima Y; Hayashi H; Yamamoto N; Matsuyama T; Igawa T; Sakai H; Kubo Y
Biochem Biophys Res Commun; 2014 Apr; 447(1):216-22. PubMed ID: 24721431
[TBL] [Abstract][Full Text] [Related]
15. Moloney murine leukemia virus glyco-gag facilitates xenotropic murine leukemia virus-related virus replication through human APOBEC3-independent mechanisms.
Nitta T; Lee S; Ha D; Arias M; Kozak CA; Fan H
Retrovirology; 2012 Jul; 9():58. PubMed ID: 22828015
[TBL] [Abstract][Full Text] [Related]
16. No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.
Stieler K; Schindler S; Schlomm T; Hohn O; Bannert N; Simon R; Minner S; Schindler M; Fischer N
PLoS One; 2011; 6(10):e25592. PubMed ID: 22022417
[TBL] [Abstract][Full Text] [Related]
17. Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells.
Rodriguez JJ; Goff SP
J Virol; 2010 Mar; 84(5):2556-62. PubMed ID: 20015990
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.
Paprotka T; Venkatachari NJ; Chaipan C; Burdick R; Delviks-Frankenberry KA; Hu WS; Pathak VK
J Virol; 2010 Jun; 84(11):5719-29. PubMed ID: 20335265
[TBL] [Abstract][Full Text] [Related]
19. Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome.
Menéndez-Arias L
Rev Med Virol; 2011 Jan; 21(1):3-17. PubMed ID: 21294212
[TBL] [Abstract][Full Text] [Related]
20. Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer.
Kim S; Kim N; Dong B; Boren D; Lee SA; Das Gupta J; Gaughan C; Klein EA; Lee C; Silverman RH; Chow SA
J Virol; 2008 Oct; 82(20):9964-77. PubMed ID: 18684813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
